LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 66 filers reported holding LARIMAR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $445,560 | +3.3% | 112,800 | -18.1% | 0.01% | +10.0% |
| Q2 2023 | $431,314 | -30.9% | 137,800 | 0.0% | 0.01% | -41.2% |
| Q1 2023 | $624,234 | +140.7% | 137,800 | +119.4% | 0.02% | +142.9% |
| Q4 2022 | $259,364 | -33.3% | 62,800 | -48.4% | 0.01% | -30.0% |
| Q3 2022 | $389,000 | +63.4% | 121,599 | 0.0% | 0.01% | +100.0% |
| Q2 2022 | $238,000 | -6.3% | 121,599 | +93.6% | 0.01% | 0.0% |
| Q1 2022 | $254,000 | -62.5% | 62,800 | 0.0% | 0.01% | -61.5% |
| Q4 2021 | $678,000 | +132.2% | 62,800 | +214.0% | 0.01% | +160.0% |
| Q1 2021 | $292,000 | +88.4% | 20,000 | +95.1% | 0.01% | +25.0% |
| Q3 2020 | $155,000 | – | 10,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,414,468 | $8,720,383 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $53,026,447 | 1.13% |
| Opaleye Management Inc. | 1,390,000 | $4,350,700 | 1.04% |
| DAFNA Capital Management LLC | 350,373 | $1,096,667 | 0.30% |
| MANGROVE PARTNERS IM, LLC | 805,815 | $2,522,201 | 0.18% |
| Atlas Venture Advisors, Inc. | 292,184 | $914,536 | 0.16% |
| Verition Fund Management LLC | 2,716,713 | $8,503,312 | 0.11% |
| Woodline Partners LP | 1,681,913 | $5,264,388 | 0.06% |
| Fi3 FINANCIAL ADVISORS, LLC | 25,548 | $79,965 | 0.04% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 363,505 | $1,137,771 | 0.04% |